CPR Stock Overview
Compremum S.A. engages in the manufacture and sale of windows and doors in Europe.
Price History & Performance
|Historical stock prices|
|Current Share Price||zł2.47|
|52 Week High||zł5.48|
|52 Week Low||zł2.32|
|1 Month Change||-1.98%|
|3 Month Change||-0.40%|
|1 Year Change||-48.75%|
|3 Year Change||12.27%|
|5 Year Change||6.01%|
|Change since IPO||0.41%|
Recent News & Updates
Compremum (WSE:CPR) Is Looking To Continue Growing Its Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
What Does Compremum S.A.'s (WSE:CPR) Share Price Indicate?
Compremum S.A. ( WSE:CPR ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
|CPR||PL Building||PL Market|
Return vs Industry: CPR underperformed the Polish Building industry which returned -31.3% over the past year.
Return vs Market: CPR underperformed the Polish Market which returned -20.9% over the past year.
|CPR Average Weekly Movement||5.6%|
|Building Industry Average Movement||6.2%|
|Market Average Movement||6.3%|
|10% most volatile stocks in PL Market||12.1%|
|10% least volatile stocks in PL Market||4.2%|
Stable Share Price: CPR is not significantly more volatile than the rest of Polish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CPR's weekly volatility (6%) has been stable over the past year.
About the Company
Compremum S.A. engages in the manufacture and sale of windows and doors in Europe. The company operates through Joinery, Construction Services, Development Services, Railway Industry, and Renewable Energy Sources segments. It offers wooden, wooden-aluminum, and aluminum windows; patio doors; wooden external and terrace doors; and facades offers under the SLONAWY brand.
Compremum Fundamentals Summary
|CPR fundamental statistics|
Is CPR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CPR income statement (TTM)|
|Cost of Revenue||zł165.03m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Sep 29, 2022
|Earnings per share (EPS)||0.56|
|Net Profit Margin||11.94%|
How did CPR perform over the long term?See historical performance and comparison
Is CPR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CPR?
Other financial metrics that can be useful for relative valuation.
|What is CPR's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does CPR's PE Ratio compare to its peers?
|CPR PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
PJP PJP Makrum
Price-To-Earnings vs Peers: CPR is good value based on its Price-To-Earnings Ratio (4.4x) compared to the peer average (13.2x).
Price to Earnings Ratio vs Industry
How does CPR's PE Ratio compare vs other companies in the European Building Industry?
Price-To-Earnings vs Industry: CPR is good value based on its Price-To-Earnings Ratio (4.4x) compared to the Polish Building industry average (8.5x)
Price to Earnings Ratio vs Fair Ratio
What is CPR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||4.4x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CPR's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of CPR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate CPR's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CPR's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Compremum forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Compremum has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has Compremum performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CPR has high quality earnings.
Growing Profit Margin: CPR's current net profit margins (11.9%) are lower than last year (15.2%).
Past Earnings Growth Analysis
Earnings Trend: CPR's earnings have grown significantly by 45.6% per year over the past 5 years.
Accelerating Growth: CPR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CPR had negative earnings growth (-16.9%) over the past year, making it difficult to compare to the Building industry average (32.4%).
Return on Equity
High ROE: CPR's Return on Equity (9.9%) is considered low.
Discover strong past performing companies
How is Compremum's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CPR's short term assets (PLN324.7M) exceed its short term liabilities (PLN176.1M).
Long Term Liabilities: CPR's short term assets (PLN324.7M) exceed its long term liabilities (PLN94.9M).
Debt to Equity History and Analysis
Debt Level: CPR's net debt to equity ratio (34.2%) is considered satisfactory.
Reducing Debt: CPR's debt to equity ratio has reduced from 36.7% to 36.4% over the past 5 years.
Debt Coverage: CPR's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: CPR's interest payments on its debt are well covered by EBIT (23.7x coverage).
Discover healthy companies
What is Compremum current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CPR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CPR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CPR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CPR's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: CPR is not paying a notable dividend for the Polish market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CPR has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Compremum has no CEO, or we have no data on them.
Experienced Board: CPR's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Compremum S.A.'s employee growth, exchange listings and data sources
- Name: Compremum S.A.
- Ticker: CPR
- Exchange: WSE
- Founded: 1973
- Industry: Building Products
- Sector: Capital Goods
- Implied Market Cap: zł110.747m
- Shares outstanding: 44.84m
- Website: https://compremum.pl
Number of Employees
- Compremum S.A.
- ul. Gryfinska 1
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/17 00:00|
|End of Day Share Price||2022/08/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.